---

Health

Yes, everyone should have a cancer drugs fund, but those funds should be reactive to what works for people. If I have time, I want to talk about ipilimumab too. It is a difficult name to say, but it is also known as Yervoy. The hon. Lady should talk to the Government in Scotland and ask them to do what we are doing here in this country. They have devolved powers that were voted for by this House—and which I do not agree with—but they have them, and they must make their own decisions. The cancer drugs fund in the east midlands is not fit for purpose. It is not working for the benefit of patients. The people involved say that they need the necessary clinical knowledge of these cases, but they already have it. The consultant has written to them, as have I, and they can see that those patients are still alive. They are still failing miserably, however, to help my two constituents, who will die if they do not get the drug. I hope that the Minister will contact those people and ask them to work more efficiently and effectively to help those patients who rely desperately on them to provide the necessary drugs. I want briefly to talk about Yervoy, which is also known by that other name that I cannot pronounce. It is used to treat malignant melanoma. I have to declare an interest, in that my brother died of malignant melanoma 11 years ago next month, before this drug was discovered. It is the first new treatment for malignant melanoma for 30 years. More people are dying of malignant melanoma than ever before, and it is on the increase. I believe that the National Institute for Health and Clinical Excellence should recommend that people should have that drug. I have heard stories of people in their 30s with young children getting the condition, and there is no hope for their future. As a responsive listening Government, we should be ensuring that those people get the drugs that they require.